Patent · US Active

Heterocyclic adenosine receptor antagonists

US11718622B2 · kind B2 · utility

0Cited by

0References

27Claims

0Family size

Assignee

Exelixis, Inc. · US

Inventors

Sunghoon Ma · Foster City, US
Yong Wang · South San Francisco, US
Wei Xu · Saginaw, US

Key dates

Filing date	Mar 15, 2021
Grant date	Aug 8, 2023
Priority date	—
Expiry date	Jun 3, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Heterocyclic compounds useful as antagonists of adenosine receptors, and methods of treatment of diseases using antagonists of adenosine receptors are disclosed herein. Also disclosed herein are pharmaceutical compositions and methods of administration of heterocyclic antagonists of adenosine receptors and processes for producing heterocyclic antagonists of adenosine receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.